Showing 981 - 1,000 results of 66,360 for search '(( 2 d decrease ) OR ( 50 ((((ms decrease) OR (a decrease))) OR (nn decrease)) ))', query time: 1.28s Refine Results
  1. 981
  2. 982
  3. 983
  4. 984
  5. 985
  6. 986

    Bcl-xL protein levels were decreased in response to siRNA transfection in A549, SK-LU1 and NP-69 cells. by Norahayu Othman (495150)

    Published 2013
    “…(<b>B</b>) Densitometry analysis of Western blot bands using the ImageJ Analyst software indicating a 92.47±0.72% reduction in Bcl-xL protein levels in A549 cells, a 98.33±0.50% reduction in SK-LU1 cells, and a 96.16±2.28% in NP-69 cells 48 h post-transfection with siRNA 1. …”
  7. 987
  8. 988
  9. 989
  10. 990

    Pacritinib effectively decreases BTIC viability and sphere forming capacity and has on-target activity on phospho-STAT3. by Katharine Victoria Jensen (4691530)

    Published 2017
    “…<p>(A) Pacritinib dramatically decreased cell viability in a dose dependent manner in eleven molecularly diverse patient-derived BTIC cultures with IC<sub>50</sub> values from 0.62 μM to 1.66 μM. …”
  11. 991
  12. 992
  13. 993
  14. 994
  15. 995
  16. 996
  17. 997

    TMEM16A knockdown decreased activation of the MEK-ERK1/2 pathway and expression of cyclin D1. by Yujie Sui (549090)

    Published 2014
    “…<p>Western blot results show inhibition of TMEM16A led to a decrease in phospho-MEK, phospho-ERK1/2 and cyclin D1. …”
  18. 998
  19. 999

    S2 Fig - by Agnieszka D. Wardak (17941139)

    Published 2024
    “…</b> Number of nosepokes during test sessions significantly decreased in subsequent test sessions for both maxima of 10 rewards (p = 0.0099, Friedman, p = 0.0391, Wilcoxon) and 30 rewards protocols (p < 0.0001, Friedman, p < 0.0001, Wilcoxon, <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0297174#pone.0297174.s005" target="_blank">S2d Table</a>). …”
  20. 1000

    Exercise testing criteria to diagnose lower extremity peripheral artery disease assessed by computed-tomography angiography by O. Stivalet (6890189)

    Published 2019
    “…The receiver-operating-characteristic curve was used to define a cut-off point corresponding to the best area under the curve (AUC; [CI95%]) to detect arterial stenosis ≥50% as determined by the CTA.…”